|
|
Page 1 of 7
| Next page
Phentermine
combined with fenfluramine ("Phen/Fen Diet"): How well does this combination
work? (written in 1995)
IMPORTANT
NOTICE:
The information below was
written before fenfluramine was withdrawn
from the market because of its association with valvular heart disease.
This information is provided to give some perspective on the use of this
combination and what went wrong.
Most
people have heard of combining phentermine with fenfluramine ("phen/fen diet") in an attempt to control weight. Michael Weintraub,
et al in a series of studies (Long-term weight control Study I , II, III,
IV, V, VI, & VII in Clin Pharmacol Ther; May 1992) studied these medications
in individuals over a period of 210 weeks. Both medications are anorexics
(appetite suppressants) that help diminish appetite by different mechanisms
of action. Phentermine is a stimulant acting through noradrenergic and dopaminergic
pathways resulting in decreased appetite and less frequent eating. Fenfluramine
acts through serotonergic mechanisms resulting in a feeling of increased
satiety. Phentermine may produce "mild" side effects such as nervousness,
irritability, insomnia, agitation, dizziness, dry mouth, constipation, elevated
blood pressure, and rapid or irregular heartbeats. Fenfluramine
may produce somewhat opposite effects with drowsiness, sedation, diarrhea,
and depression. Both medications can lead to serious side effects, with
fenfluramine being associated with primary pulmonary
hypertension, a life-threatening complication. Furthermore, in
July 1997, a new complication (valvular heart disease) was found to be
associated with the use of "phen/fen". The thinking was that by combining
these two medications, one could take advantage of their different pharmacologic
actions and get, in essence, better effectiveness while (hopefully) minimizing
the "mild" side effects. The results of the studies are summarized below.
Patient participation
Patients were 18 to 60 years of
age and weighed between 130% and 180% of their ideal body weights according
to the 1983 Metropolitan Life Insurance Tables. The patients were in good
health, not taking any long-term medications, and did not have hypertension
(high blood pressure), diabetes, or other chronic diseases.
Medication
Phentermine resin (15 mg) combined
with Fenfluramine (60 mg).
Behavior
therapy
Active and ongoing behavior therapy
with professionals trained in behavior modification techniques was an integral
part of the study. Caloric
restriction
All individuals received individualized
dietary counseling by dieticians to help limit calorie consumption to between
1500-1800 kcal per day for men and between 1000-1200 kcal per day for
women. Exercise
The participants in the study
were started on graded exercise programs to
expend at least an extra 300 kcal three times per
week over their usual daily activities. Medical
monitoring
All participants were seen by
physicians at regular intervals during the study, with periodic laboratory
and electrocardiographic monitoring.
Page 1 of 7
| Next page
|